About
Apex Immune develops monoclonal and bispecific/multi-specific antibody-based immunotherapies targeting cancer and autoimmune diseases, focusing on enhancing immune cell function to treat patients resistant to existing therapies.
Explore Apex Immune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.